NEW YORK, March 27 (Reuters) - Johnson & Johnson will get a new chance to contest the scientific evidence linking talc products to ovarian cancer, a federal judge ruled on Wednesday, potentially disrupting a federal court case that consolidates 53,000 lawsuits. (Reporting by Dietrich Knauth; Editing by Leslie Adler)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.1 USD | -0.46% | -1.20% | -6.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.76% | 352B | |
+25.83% | 661B | |
+27.00% | 566B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B | |
-11.77% | 144B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- J&J gets new opportunity to contest evidence linking talc to cancer